RFC
TOVX icon

Regions Financial Corp’s Theriva Biologics TOVX Stock Holding History

Regions Financial Corp’s Portfolio TOVX Stock Details TOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-11
Closed -$236K – 904
2016
Q1 		$236K Hold
11
– – ﹤0.01% 799
2015
Q4 		$229K Hold
11
– – ﹤0.01% 818
2015
Q3 		$227K Hold
11
– – ﹤0.01% 837
2015
Q2 		$285K Hold
11
– – ﹤0.01% 782
2015
Q1 		$219K Hold
11
– – ﹤0.01% 852
2014
Q4 		$146K Hold
11
– – ﹤0.01% 903
2014
Q3 		$178K Buy
+11
New +$179K ﹤0.01% 1074

Other funds holding TOVX

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Regions Financial Corp's TOVX Position: Q2 2016 in Review

Regions Financial Corp sold out of Theriva Biologics (TOVX) in Q2 2016, closing a stake of 11 shares — an estimated $236K sold.

Regions Financial Corp first reported a position in TOVX in Q3 2014 and held it in 7 quarters. The position peaked at $285K in Q2 2015. 61 funds tracked by Wall St. Rank hold TOVX as of Q2 2016.

  • Regions Financial Corp reported no remaining Theriva Biologics position as of Q2 2016 after selling out during the quarter.
  • Regions Financial Corp sold 11 Theriva Biologics shares in Q2 2016, an estimated $236K.
  • Regions Financial Corp first reported a position in Theriva Biologics in Q3 2014 and held it in 7 quarters.
  • Regions Financial Corp's Theriva Biologics position peaked at $285K in Q2 2015.
  • 61 funds tracked by Wall St. Rank held Theriva Biologics as of Q2 2016.

Based on Regions Financial Corp's 13F filing for Q2 2016, filed 26 Jul 2016.